As of December 2024, RxSight has a market cap of $1.21B. This makes RxSight the world's 6924th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.91B | 32.07% |
2023 | $1.45B | 218.23% |
2022 | $454.37M | 12.62% |
2021 | $403.44M | - |